AGENDA
Hearing on “Exploring the Growing U.S. Reliance on China's Biotech and Pharmaceutical Products”
Wednesday, July 31, 2019
Russell Senate Office Building 428A
Unable to see this video? Click here.
9:30 AM – 9:35 AM: Opening Remarks: Senator Jim Talent and Commissioner Michael Wessel
9:35 AM – 10:20 AM: Panel I: Administration Views on Chinese Pharmaceutical, Medical Product, and Biotechnology Development and Sourcing
- Christopher Priest, Chief of Staff, Defense Health Agency Operations Directorate (J-3) [Testimony]
- Mark Abdoo, Associate Commissioner for Global Policy and Strategy, Food and Drug Administration [Statement for the Record]
10:35: AM – 12:35 PM: Panel II: China’s Role in Global Health and Activities in the United States
- Rosemary Gibson, Senior Advisor, Hastings Center, Author, “China Rx” [Testimony]
- Ben Westhoff, Author, “Fentanyl, Inc.” [Testimony]
- Dr. Jennifer Bouey, Tang Chair in China Policy Studies, RAND Corporation; Associate Professor, Georgetown University’s School of Nursing and Health Studies [Testimony]
- Dr. Mark Kazmierczak, Scientist and Associate, Gryphon Scientific LLC [Testimony]
12:35 PM – 1:30 PM: Lunch Break
1:30 PM – 3:30 PM: Panel III: U.S.-China Links in Health and Medical Products: Risks and Opportunities
- Benjamin Shobert, Director of Strategy for Health Business Strategy, Microsoft; Senior Associate, National Bureau of Asian Research [Testimony]
- Katherine Eban, Author, “Bottle of Lies” [Testimony]
- Dr. Yanzhong Huang, Senior Fellow for Global Health, Council on Foreign Relations; Professor, School of Diplomacy and International Relations, Seton Hall University [Testimony]
- Craig Allen, President, US-China Business Council [Testimony]
3:35 PM: Adjourn
Transcript